ATG4B/MB10290 antibody (Cat. #AM1902b) western blot analysis in MCF-7 cell line lysates (35ug/lane).This demonstrates the ATG4B/MB10290 antibody detected the ATG4B/MB10290 protein (arrow).
Cysteine protease required for autophagy, which cleaves the C-terminal part of MAP1LC3, GABARAPL1, GABARAPL2 and GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes. Also mediates the lipid deconjugation required for target recycling
Tissue Specificity
Mainly expressed in the skeletal muscle, followed by brain, heart, liver and pancreas
ATG4B/MB10290 antibody (Cat. #AM1902b) western blot analysis in MCF-7 cell line lysates (35ug/lane).This demonstrates the ATG4B/MB10290 antibody detected the ATG4B/MB10290 protein (arrow).
Application Notes
WB:1:100~250
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Storage Buffer
Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Euglobin precipitation followed by dialysis against PBS.